AMN Healthcare Services, Inc. (AMN)
NYSE: AMN · IEX Real-Time Price · USD
57.03
+1.25 (2.24%)
At close: Jul 19, 2024, 4:00 PM
57.05
+0.02 (0.04%)
After-hours: Jul 20, 2024, 12:58 PM EDT
AMN Healthcare Services Market Cap
AMN Healthcare Services has a market cap or net worth of $2.17 billion as of July 22, 2024. Its market cap has decreased by -49.73% in one year.
Market Cap
2.17B
Enterprise Value
3.31B
1-Year Change
-49.73%
Ranking
Category
Stock Price
$57.03
Market Cap Chart
Since November 13, 2001, AMN Healthcare Services's market cap has increased from $881.10M to $2.17B, an increase of 145.94%. That is a compound annual growth rate of 4.04%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 2.17B | -23.42% |
Dec 29, 2023 | 2.83B | -36.49% |
Dec 30, 2022 | 4.46B | -22.95% |
Dec 31, 2021 | 5.78B | 80.17% |
Dec 31, 2020 | 3.21B | 10.28% |
Dec 31, 2019 | 2.91B | 9.61% |
Dec 31, 2018 | 2.66B | 12.87% |
Dec 29, 2017 | 2.35B | 27.35% |
Dec 30, 2016 | 1.85B | 24.76% |
Dec 31, 2015 | 1.48B | 62.02% |
Dec 31, 2014 | 914.00M | 35.15% |
Dec 31, 2013 | 676.30M | 31.91% |
Dec 31, 2012 | 512.70M | 186.10% |
Dec 30, 2011 | 179.20M | -25.36% |
Dec 31, 2010 | 240.10M | -18.78% |
Dec 31, 2009 | 295.60M | 7.26% |
Dec 31, 2008 | 275.60M | -52.55% |
Dec 31, 2007 | 580.80M | -38.02% |
Dec 29, 2006 | 937.10M | 64.66% |
Dec 30, 2005 | 569.10M | 26.19% |
Dec 31, 2004 | 451.00M | -6.53% |
Dec 31, 2003 | 482.50M | -33.63% |
Dec 31, 2002 | 727.00M | -34.83% |
Dec 31, 2001 | 1.12B | 26.61% |
View and export this data all the way back to 2001.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Janux Therapeutics | 2.23B |
Patterson Companies | 2.20B |
Addus HomeCare | 2.14B |
Structure Therapeutics | 2.13B |
LifeStance Health Group | 2.12B |
CONMED | 2.11B |
Beam Therapeutics | 2.10B |
Protagonist Therapeutics | 2.08B |